Endocrinology Drugs Market To Record Lucrative Growth, Expanding at 5.5% of CAGR

March 2022 | Report Format: Electronic (PDF)

Because of the rising prevalence of endocrine diseases, the global endocrinology drugs market is expected to grow at a rapid pace over the forecast period. Endocrine gland disorders such as Addison's disease, gigantism, goitre, Cushing's syndrome, polycystic ovary syndrome (PCOS), diabetes, hypertension, hyperlipidemia, acromegaly, thyroiditis, and osteomalacia are examples of these diseases. The growing adolescent population, which is more susceptible to such diseases due to hormonal imbalances, is also driving the growth of the endocrinology drugs market. Unhealthy lifestyle factors such as high cholesterol intake, work stress, and weight gain, which ultimately leads to endocrine system malfunctioning, the introduction of new drug delivery systems, extensive research and development, and an increase in disposable income drive the growth of the endocrinology drugs market.

Request a Free Sample Copy: Endocrinology Drugs Market Report

Endocrinology Drugs Market Report Highlights

• In September 2021, AstraZeneca invested $360m in advanced manufacturing facility in near Dublin, Ireland to establish a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules to ensure the Company’s global supply network is fit for future grow.
• In June 2021, Merck completed the spinoff of Organon & Co. to form an independent, publicly traded company with a broad portfolio of important medicines and products, and is fully prepared to deliver sustainable growth and value.

ENDOCRINOLOGY DRUGS MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Endocrinology Drugs Product Type Outlook (Revenue, USD Million, 2016 - 2027)

• Diabetes Drugs
• Testosterone Replacement Drugs
• Human Growth Hormone Drugs
• Thyroid Hormone Disorder Drugs
• Others

Endocrinology Drugs Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals and Clinics
• Pharmacy Stores
• Supermarkets
• Online Platforms

Endocrinology Drugs Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa

List of Key Players- Endocrinology Drugs Market

• Acerus Pharmaceuticals Corp.
• Beta Cell NV
• GlaxoSmithKline Plc
• Eli Lily
• Ipsen Pharma SA
• Merck and Co. Inc.
• Novartis AG
• Novo Nordisk
• Pfizer
• Sanofi SA
• AbbVie
• AstraZeneca

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions.

Contact Us:

Market Research Strategy

473 Mundet Place,

Ste US520501 Hillside

New Jersey 07205 United States

USA Phone: ++1 9176726599

Business Email: sales@marketresearchstrategy.com

Website: https://marketresearchstrategy.com/